| Gene ID | 5444 |
| Symbol | PON1 |
| Synonymous | ESA|MVCD5|PON |
| Full name | paraoxonase 1 |
| Gene description | A-esterase 1|K-45|PON 1|aromatic esterase 1|arylesterase 1|arylesterase B-type|esterase A|paraoxonase B-type|serum aryldiakylphosphatase|serum aryldialkylphosphatase 1|serum paraoxonase/arylesterase 1 |
| Cytoband | 7q21.3 |
| Gene type | protein-coding |
| Synonymous | MIM:168820; HGNC:HGNC:9204; HPRD:01351 |
Pathways and Diseases | Detail |
|---|---|
Pathway | Metabolic pathways;KEGG PATHWAY;hsa01100 |
Disease | paraoxonase-1;GAD |
Disease | coronary heart disease;GAD |
Disease | fasting total cholesterol and LDL-cholesterol concentrations only;GAD |
Disease | triglycerides;GAD |
Disease | longevity;GAD |
Disease | Coronary Stenosis;GAD |
Disease | IMMUNE;GAD |
Disease | Parkinson's disease;GAD |
Disease | glucose;GAD |
Disease | carotid artery damage;GAD |
Disease | INFECTION;GAD |
Disease | plasma lipoproteins;GAD |
Disease | PSYCH;GAD |
Disease | heart disease, ischemic;GAD |
Disease | myocardial infarct stroke, ischemic;GAD |
Disease | Stroke;GAD |
Disease | chronic symptoms in pesticide-exposed workers;GAD |
Disease | Carotid Artery Diseases;GAD |
Disease | organophosphate toxicity;GAD |
Disease | Amyotrophic Lateral Sclerosis;GAD |
Disease | C-reactive protein;GAD |
Disease | Macular Degeneration;GAD |
Disease | myocardial infarct;GAD |
Disease | Atherosclerosis;FunDO |
Disease | breast cancer;GAD |
Disease | cardiovascular;GAD |
Disease | cholesterol, total;GAD |
Disease | Coronary artery spasm 2, susceptibility to;OMIM |
Disease | nephropathy, IgA;GAD |
Disease | response to TNF antagonist treatment;GAD |
Disease | AGING;GAD |
Disease | hypertension;GAD |
Disease | stroke, ischemic;GAD |
Disease | atherosclerosis, coronary;GAD |
Disease | hyperglycemia hypertension, pregnancy induced preterm delivery;GAD |
Disease | cardiovascular disease;GAD |
Disease | prostate cancer;GAD |
Disease | beta-cell function;GAD |
Disease | Insulin Resistance;GAD |
Disease | osteonecrosis;GAD |
Disease | glomerulosclerosis, focal;GAD |
Disease | diabetes, type 1;GAD |
Disease | glucose response;GAD |
Disease | bone mineral density (BMD);GAD |
Disease | NORMALVARIATION;GAD |
Disease | Hepatitis C, Chronic;GAD |
Disease | pesticide toxicity;GAD |
Disease | cerebral infarct;GAD |
Disease | schizophrenia;GAD |
Disease | Alzheimer's Disease/Coronary artery disease;GAD |
Disease | Coronary artery disease, susceptibility to;OMIM |
Disease | non-Hodgkin's lymphoma;GAD |
Disease | cholesterol, HDL;GAD |
Disease | ALS/amyotrophic lateral sclerosis;GAD |
Disease | atherosclerosis, coronary cholesterol, HDL triglycerides;GAD |
Disease | PHARMACOGENOMIC;GAD |
Disease | METABOLIC;GAD |
Disease | Schizophrenia;FunDO |
Disease | paraoxinase 1 activity;GAD |
Disease | body mass paraoxonase activity polycystic ovary syndrome;GAD |
Disease | Retinal disease;FunDO |
Disease | albumin excretion rate;GAD |
Disease | hypercholesterolemia;GAD |
Disease | Coronary Artery Disease;GAD |
Disease | Organophosphate poisoning, sensitivity to;OMIM |
Disease | CARDIOVASCULAR;GAD |
Disease | insulin;GAD |
Disease | REPRODUCTION;GAD |
Disease | retinopathy, diabetic;GAD |
Disease | HDL-cholesterol level;GAD |
Disease | abdominal aortic aneurysm homocysteine hypertension;GAD |
Disease | more degree of homeostasis model assessment IR;GAD |
Disease | Atherosclerosis;GAD |
Disease | oxidative stress;GAD |
Disease | preterm delivery;GAD |
Disease | Alzheimer's disease;GAD |
Disease | lipids;GAD |
Disease | carotid atherosclerosis;GAD |
Disease | diabetes, type 2;GAD |
Disease | vascular disease;GAD |
Disease | Crohn's disease ulcerative colitis;GAD |
Disease | intima media thickness;GAD |
Disease | VISION;GAD |
Disease | nephropathy in other diseases;GAD |
Disease | Multiple Chemical Sensitivity;GAD |
Disease | acetylcholinesterase;GAD |
Disease | coronary artery spasm;GAD |
Disease | increased serum glucose concentrations;GAD |
Disease | bone density;GAD |
Disease | Diabetes mellitus;FunDO |
Disease | lipoprotein, LDL;GAD |
Disease | Microvascular complications of diabetes, susceptibility to, 5;OMIM |
Disease | CANCER;GAD |
Disease | Myocardial Infarction;GAD |
Disease | Kidney failure;FunDO |
Disease | carotid intima-media thickness;GAD |
Disease | NEUROLOGICAL;GAD |
Disease | glaucoma, primary open-angle;GAD |
Disease | cholesterol, LDL;GAD |
Disease | paraoxonase;GAD |
Disease | childhood brain tumor;GAD |
Disease | Response to TNF antagonist treatment;NHGRI |
Disease | lipid concentrations;GAD |
Disease | RENAL;GAD |
Sequence Information | |
|---|---|
Nucleotide Sequence | >5444 : length: 1769 AATCGGCGCTGCCCCAGCAGGGCTGCGGCTGCAGGCAGGCAGAGCCTCCTAGCCCGTCGGTGTCTGCGCCCATCGATCCCTTTGTCTATCCCCGACCATGGCGAAGCTGATTGCGCTCAC CCTCTTGGGGATGGGACTGGCACTCTTCAGGAACCACCAGTCTTCTTACCAAACACGACTTAATGCTCTCCGAGAGGTACAACCCGTAGAACTTCCTAACTGTAATTTAGTTAAAGGAAT CGAAACTGGCTCTGAAGACTTGGAGATACTGCCTAATGGACTGGCTTTCATTAGCTCTGGATTAAAGTATCCTGGAATAAAGAGCTTCAACCCCAACAGTCCTGGAAAAATACTTCTGAT GGACCTGAATGAAGAAGATCCAACAGTGTTGGAATTGGGGATCACTGGAAGTAAATTTGATGTATCTTCATTTAACCCTCATGGGATTAGCACATTCACAGATGAAGATAATGCCATGTA CCTCCTGGTGGTGAACCATCCAGATGCCAAGTCCACAGTGGAGTTGTTTAAATTTCAAGAAGAAGAAAAATCGCTTTTGCATCTAAAAACCATCAGACATAAACTTCTGCCTAATTTGAA TGATATTGTTGCTGTGGGACCTGAGCACTTTTATGGCACAAATGATCACTATTTTCTTGACCCCTACTTACAATCCTGGGAGATGTATTTGGGTTTAGCGTGGTCGTATGTTGTCTACTA TAGTCCAAGTGAAGTTCGAGTGGTGGCAGAAGGATTTGATTTTGCTAATGGAATCAACATTTCACCCGATGGCAAGTATGTCTATATAGCTGAGTTGCTGGCTCATAAGATTCATGTGTA TGAAAAGCATGCTAATTGGACTTTAACTCCATTGAAGTCCCTTGACTTTAATACCCTCGTGGATAACATATCTGTGGATCCTGAGACAGGAGACCTTTGGGTTGGATGCCATCCCAATGG CATGAAAATCTTCTTCTATGACTCAGAGAATCCTCCTGCATCAGAGGTGCTTCGAATCCAGAACATTCTAACAGAAGAACCTAAAGTGACACAGGTTTATGCAGAAAATGGCACAGTGTT GCAAGGCAGTACAGTTGCCTCTGTGTACAAAGGGAAACTGCTGATTGGCACAGTGTTTCACAAAGCTCTTTACTGTGAGCTCTAACAGACCGATTTGCACCCATGCCATAGAAACTGAGG CCATTATTTCAACCGCTTGCCATATTCCGAGGACCCAGTGTTCTTAGCTGAACAATGAATGCTGACCCTAAATGTGGACATCATGAAGCATCAAAGCACTGTTTAACTGGGAGTGATATG ATGTGTAGGGCTTTTTTTTGAGAATACACTATCAAATCAGTCTTGGAATACTTGAAAACCTCATTTACCATAAAAATCCTTCTCACTAAAATGGATAAATCAGTTATGTCAATTGTCAGA TATTAAATAACAGTGTGTGACCCCAAAAGTACTTACCCTAAAACATGTGTTGCCTGGAAGCACATGTGTGTATCGCTGCCTTGCCATGTCTTGTTCAGAAGACACAGGGGAGCAGGGTTA GCTCACGTGTCTTTAGAACTCCAGTACTCACCCAGGGACTCCAGTTCACAGGCCAGAAAACATATGCATTATGAAGTTCCCCTCTACTCCATGCACATAGTAAGTCTGACTATGGCAGTC AGACTTACTTACTCCCATTTTCCCTTCGATATATGACTTTTTCTCAGTAAATATTAACCTGAATTATTCCAAAAAAAAAAAAAAAAAAA |
Protein Sequence | >5444 : length: 355 MAKLIALTLLGMGLALFRNHQSSYQTRLNALREVQPVELPNCNLVKGIETGSEDLEILPNGLAFISSGLKYPGIKSFNPNSPGKILLMDLNEEDPTVLELGITGSKFDVSSFNPHGISTF TDEDNAMYLLVVNHPDAKSTVELFKFQEEEKSLLHLKTIRHKLLPNLNDIVAVGPEHFYGTNDHYFLDPYLQSWEMYLGLAWSYVVYYSPSEVRVVAEGFDFANGINISPDGKYVYIAEL LAHKIHVYEKHANWTLTPLKSLDFNTLVDNISVDPETGDLWVGCHPNGMKIFFYDSENPPASEVLRIQNILTEEPKVTQVYAENGTVLQGSTVASVYKGKLLIGTVFHKALYCEL |